Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2903076 | 0.98 | TSHR (0.59) | TSHRFAAHTRPV1CYP3A4ALDH1A1 | |
| SCHEMBL8840933 | 0.93 | TSHR (0.61) | TSHRFAAHTRPV1CYP3A4ALDH1A1 | |
| SCHEMBL11498365 | 0.93 | TSHR (0.61) | TSHRFAAHTRPV1CYP3A4ALDH1A1 | |
| SCHEMBL13183507 | 0.91 | TSHR (0.65) | TSHRFAAHTRPV1CYP3A4ALDH1A1 | |
| SCHEMBL13474797 | 0.91 | TSHR (0.65) | TSHRFAAHTRPV1MAPTMEN1 | |
| SCHEMBL19040831 | 0.91 | TSHR (0.65) | TSHRFAAHTRPV1CYP3A4ALDH1A1 | |
| SCHEMBL820598 | 0.91 | TSHR (0.65) | TSHRFAAHTRPV1MAPTMEN1 | |
| SCHEMBL1301661 | 0.91 | TSHR (0.65) | TSHRFAAHTRPV1MAPTMEN1 | |
| SCHEMBL27916603 | 0.91 | TSHR (0.65) | TSHRFAAHTRPV1CYP3A4ALDH1A1 | |
| SCHEMBL883374 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| US-11773061-B2 | Cyclic lipids and methods of use thereof | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-2883858-B1 | METHOD FOR PRODUCING HEXAHYDROFUROFURANOL DERIVATIVE | SUMITOMO CHEMICAL CO (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-9809566-B2 | Organocatalytic process for asymmetric synthesis of decanolides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-11-07 | — | — | US | disclosed |
| US-9765048-B2 | Organocatalytic process for asymmetric synthesis of decanolides | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2017-09-19 | — | — | US | disclosed |
| US-9670232-B2 | Molecular precursor compounds for zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2017-06-06 | — | — | US | disclosed |
| US-9455142-B2 | Molecular precursor compounds for ABIGZO zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-09-27 | — | — | US | disclosed |
| US-20160272608-A1 | ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-09-22 | — | — | US | disclosed |
| US-20160272609-A1 | ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-09-22 | — | — | US | disclosed |
| WO-1988005767-A1 | HYDROGENATION PROCESS | DAVY MCKEE (LONDON) LIMITED (GB) | 1988-08-11 | — | — | WO | disclosed |
| EP-0277168-A1 | PROCESS FOR THE CO-PRODUCTION OF BUTANE-1,4-DIOL AND $i(GAMMA)-BUTYROLACTONE | DAVY McKEE (LONDON) LIMITED (GB) | 1988-08-10 | — | — | EP | disclosed |
| WO-1988000937-A1 | PROCESS FOR THE CO-PRODUCTION OF BUTANE-1,4-DIOL AND GAMMA-BUTYROLACTONE | DAVY MCKEE (LONDON) LIMITED (GB) | 1988-02-11 | — | — | WO | disclosed |
| WO-1987007598-A1 | PROCESS FOR HYDROGENATING AN UNSATURATED ORGANIC COMPOUND | DAVY MCKEE (LONDON) LIMITED (GB) | 1987-12-17 | — | — | WO | disclosed |
| EP-0223814-A1 | PROCESS FOR THE PRODUCTION OF $i(GAMMA)-BUTYROLACTONE | DAVY McKEE (LONDON) LIMITED (GB) | 1987-06-03 | — | — | EP | disclosed |
| WO-1986007358-A1 | PROCESS FOR THE PRODUCTION OF GAMMA-BUTYROLACTONE | DAVY MCKEE (LONDON) LIMITED (GB) | 1986-12-18 | — | — | WO | disclosed |
| EP-0204730-A1 | PROCESS FOR THE PRODUCTION OF BUTANE-1,4-DIOL | DAVY McKEE (LONDON) LIMITED (GB) | 1986-12-17 | — | — | EP | disclosed |
| WO-1986003189-A1 | PROCESS FOR THE PRODUCTION OF BUTANE-1,4-DIOL | DAVY MCKEE (LONDON) LIMITED (GB) | 1986-06-05 | — | — | WO | disclosed |
| EP-0024532-A1 | Tert. butoxybutanales and butanoles and bis-tert. butoxy-pentanales and pentanoles, their production and their use as perfumes | BASF Aktiengesellschaft (DE) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272609-A1 | ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES | CDC14A, CDC14B, DDOST | TSHR 4683/4885FAAH 3873/4885TRPV1 1685/4885 |
| US-11773061-B2 | Cyclic lipids and methods of use thereof | SGMS1, SGMS2, LNPEP | TSHR 2474/4885FAAH 2169/4885TRPV1 3200/4885 |
| US-20160272608-A1 | ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES | CDC14A, CDC14B, DDOST | TSHR 4683/4885FAAH 3873/4885TRPV1 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.